Sign in

NCT04968743Completed

Phase-dependent Evaluation of Motor Cortex Excitability With TMS in Stroke

Source: ClinicalTrials.gov · Last updated 14 Sept 2026

Brief summary (registry, in English)

The purpose of this study is to investigate the effects of transcranial magnetic stimulation (TMS) on motor cortex excitability in individuals who have suffered stroke and to study the influence of the phase of the oscillatory rhythm (mu frequency) on motor excitability in stroke individuals.

Status (registry)
Completed
Study type
Interventional
Enrollment
24 (actual)
First submitted
16 Jul 2021
Start date
1 Oct 2021
Primary completion date
1 Oct 2025
Lead sponsor
University of Minnesota
Diseases
Stroke
NCT number
NCT04968743

What you commit to

  • Study type: Interventional
  • Participants enrolled: 24
  • From 1 Oct 2021 to the primary completion date, 1 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Metal or electric implant in the head, neck, or chest area
  • Prior occurrence of unprovoked seizure

Other

  • Upper extremity botulinum toxin treatment in the last 6 months
  • Pregnancy or breastfeeding

Who the study is looking for

  • Suffering from chronic stroke, resulting in self-reported motor deficits (stroke occurring more than 6 months before study enrollment)
  • Confident level of English language

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of Minnesota
Coordinator of this site? Confirm its status
MinneapolisUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.